This is an old revision of this page, as edited by Tom.Reding (talk | contribs) at 00:51, 30 June 2016 (→External links: Rem stub tag(s) (class = non-stub & non-list) using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | This article needs more links to other articles to help integrate it into the encyclopedia. Please help improve this article by adding links that are relevant to the context within the existing text. (December 2015) (Learn how and when to remove this message) |
The Patented Medicine Prices Review Board is a government agency in Canada which regulates drugs that are still under patent and which yet have no generic substitutes.
This Board establishes the maximum prices that can be charged in Canada for patented drugs.[1]
